127 related articles for article (PubMed ID: 8173235)
1. High-efficiency gene transfer employing adenovirus-polylysine-DNA complexes.
Curiel DT
Nat Immun; 1994; 13(2-3):141-64. PubMed ID: 8173235
[TBL] [Abstract][Full Text] [Related]
2. Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway.
Michael SI; Curiel DT
Gene Ther; 1994 Jul; 1(4):223-32. PubMed ID: 7584085
[TBL] [Abstract][Full Text] [Related]
3. Receptor-mediated gene transfer to airway epithelial cells in primary culture.
Harris CE; Agarwal S; Hu P; Wagner E; Curiel DT
Am J Respir Cell Mol Biol; 1993 Oct; 9(4):441-7. PubMed ID: 8398183
[TBL] [Abstract][Full Text] [Related]
4. Methods for Gene Transfer Using DNA-Adenovirus Conjugates.
Curiel DT
Methods Mol Med; 1997; 7():1-23. PubMed ID: 24493415
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer to respiratory epithelial cells via the receptor-mediated endocytosis pathway.
Curiel DT; Agarwal S; Rømer MU; Wagner E; Cotten M; Birnstiel ML; Boucher RC
Am J Respir Cell Mol Biol; 1992 Mar; 6(3):247-52. PubMed ID: 1540389
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer by adenovirus-mimetic peptides in the presence of a cationic lipid and/or adenovirus. Analysis of the contribution of the viral and nonviral components.
Moritz S; Colin M; Keller M; Klonjkowski B; Capeau J; Coutelle C; Chroboczek J; Brahimi-Horn MC
Arch Virol; 2003 Jan; 148(1):1-18. PubMed ID: 12536292
[TBL] [Abstract][Full Text] [Related]
8. Biophysical targeting of adenovirus vectors for gene therapy.
Silman NJ; Fooks AR
Curr Opin Mol Ther; 2000 Oct; 2(5):524-31. PubMed ID: 11249755
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor.
Cristiano RJ; Roth JA
Cancer Gene Ther; 1996; 3(1):4-10. PubMed ID: 8785711
[TBL] [Abstract][Full Text] [Related]
10. Highly efficient and consistent gene transfer into dendritic cells utilizing a combination of ultraviolet-irradiated adenovirus and poly(L-lysine) conjugates.
Mulders P; Pang S; Dannull J; Kaboo R; Hinkel A; Michel K; Tso CL; Roth M; Belldegrun A
Cancer Res; 1998 Mar; 58(5):956-61. PubMed ID: 9500456
[TBL] [Abstract][Full Text] [Related]
11. Ligand substitution of receptor targeted DNA complexes affects gene transfer into hepatoma cells.
Ziady AG; Ferkol T; Gerken T; Dawson DV; Perlmutter DH; Davis PB
Gene Ther; 1998 Dec; 5(12):1685-97. PubMed ID: 10023448
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cellular uptake and gene transfer efficiency of pegylated poly-L-lysine compacted DNA: implications for cancer gene therapy.
Walsh M; Tangney M; O'Neill MJ; Larkin JO; Soden DM; McKenna SL; Darcy R; O'Sullivan GC; O'Driscoll CM
Mol Pharm; 2006; 3(6):644-53. PubMed ID: 17140252
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer into human hepatoma cells by receptor-associated protein/polylysine conjugates.
Kim TG; Kang SY; Kang JH; Cho MY; Kim JI; Kim SH; Kim JS
Bioconjug Chem; 2004; 15(2):326-32. PubMed ID: 15025528
[TBL] [Abstract][Full Text] [Related]
14. Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity.
Krasnykh V; Dmitriev I; Navarro JG; Belousova N; Kashentseva E; Xiang J; Douglas JT; Curiel DT
Cancer Res; 2000 Dec; 60(24):6784-7. PubMed ID: 11156365
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery.
Curiel DT; Agarwal S; Wagner E; Cotten M
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8850-4. PubMed ID: 1681545
[TBL] [Abstract][Full Text] [Related]
16. Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein.
Gonzalez R; Vereecque R; Wickham TJ; Vanrumbeke M; Kovesdi I; Bauters F; Fenaux P; Quesnel B
Gene Ther; 1999 Mar; 6(3):314-20. PubMed ID: 10435081
[TBL] [Abstract][Full Text] [Related]
17. Targeted gene delivery by tropism-modified adenoviral vectors.
Douglas JT; Rogers BE; Rosenfeld ME; Michael SI; Feng M; Curiel DT
Nat Biotechnol; 1996 Nov; 14(11):1574-8. PubMed ID: 9634824
[TBL] [Abstract][Full Text] [Related]
18. Targeting of adenoviral vectors through a bispecific single-chain antibody.
Haisma HJ; Grill J; Curiel DT; Hoogeland S; van Beusechem VW; Pinedo HM; Gerritsen WR
Cancer Gene Ther; 2000 Jun; 7(6):901-4. PubMed ID: 10880021
[TBL] [Abstract][Full Text] [Related]
19. Use of protamine to augment adenovirus-mediated cancer gene therapy.
Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
[TBL] [Abstract][Full Text] [Related]
20. Copolymers of poly-L-lysine with serine and tryptophan form stable DNA vectors: implications for receptor-mediated gene transfer.
Gómez-Valadés AG; Molas M; Vidal-Alabró A; Bermúdez J; Bartrons R; Perales JC
J Control Release; 2005 Jan; 102(1):277-91. PubMed ID: 15653152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
